Company Filing History:
Years Active: 2007-2013
I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.
Title: Innovator Spotlight - Pascale Alfons Rosa Dehertogh
Introduction:
Pascale Alfons Rosa Dehertogh, a male inventor based in Puurs, BE, has made significant contributions to the field of HIV drug resistance with his groundbreaking work. With two patents under his belt, Pascale is a respected figure in the medical research community.
Latest Patents:
1. Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance: Pascale's invention focuses on identifying novel mutations, mutation combinations, or mutational profiles of HIV-1 reverse transcriptase and protease genes linked to phenotypic resistance to HIV drugs. This innovative approach involves using genotypic information to interpret drug resistance, paving the way for tailored therapies and drug development.
2. Methods for measuring therapy resistance: In this patent, Pascale presents methods for measuring drug resistance by correlating genotypic details with phenotypic profiles. By analyzing genetic codes, mutation lists, and phenotype databases, these methods offer a comprehensive approach to understanding and combating drug resistance.
Career Highlights:
Currently associated with Virco N.V., Pascale continues to drive advancements in HIV drug resistance research. His expertise and dedication have led to the development of cutting-edge solutions for personalized medicine and clinical management in the fight against HIV.
Collaborations:
Throughout his career, Pascale has collaborated with esteemed professionals in the field, including Brendan Larder and Kurt Hertogs. These collaborations have been instrumental in expanding the horizons of HIV drug resistance research and treatment strategies.
Conclusion:
In conclusion, Pascale Alfons Rosa Dehertogh's work in identifying mutational profiles and measuring therapy resistance in HIV-1 has positioned him as a key player in the field of medical research. His patents and collaborations underscore his commitment to innovation and improving patient outcomes in the fight against HIV.